Imaging in translational cancer research

Felix T Kurz; Heinz-Peter Schlemmer

doi:10.20892/j.issn.2095-3941.2022.0677

Imaging in translational cancer research

Cancer Biol Med. 2022 Dec 5;19(11):1565-1585. doi: 10.20892/j.issn.2095-3941.2022.0677.

Authors

Felix T Kurz¹, Heinz-Peter Schlemmer¹

Affiliation

¹ Department of Radiology, German Cancer Research Center, Heidelberg 69120, Germany.

PMID: 36476372
PMCID: PMC9724222
DOI: 10.20892/j.issn.2095-3941.2022.0677

Abstract

This review is aimed at presenting some of the recent developments in translational cancer imaging research, with a focus on novel, recently established, or soon to be established cross-sectional imaging techniques for computed tomography (CT), magnetic resonance imaging (MRI), and positron-emission tomography (PET) imaging, including computational investigations based on machine-learning techniques.

Keywords: Cancer imaging; computed tomography (CT); cross-sectional imaging; magnetic resonance imaging (MRI); positron emission tomography (PET).

Publication types

Review

MeSH terms

Neoplasms* / diagnostic imaging
Research
Translational Research, Biomedical*